Buy, hold, sell: Judo Capital, Healius, BHP shares

Morgans has issued new notes on several stocks including BHP, which hit a new record today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares are up 0.74% to 9,168.7 points on Tuesday.

All 11 market sectors of the ASX 200 are in the green today.

Healthcare leads the pack, up 1.1%, extending its impressive recent rebound.

ARB Corporation Ltd (ASX: ARB) is the fastest riser of the ASX 200 today, up 18% on its FY26 report.

Meanwhile, Morgans has issued some new notes on three ASX shares.

They include BHP Group Ltd (ASX: BHP) shares, which hit a new all-time high today.

Let's take a look.

Woman and man at work looking at data on a tablet at work.

Image source: Getty Images

Judo Capital Holdings Ltd (ASX: JDO)

The Judo Capital share price is $1.03, up 6.4% today and down 42% over 12 months. 

Judo Capital shares are the fourth fastest riser on the local bourse despite no significant announcements today.

Morgans has a buy rating on this ASX bank share after its FY26 results.

The broker said: 

FY26 PBT landed towards the top end of the revised guidance range and FY27 guidance was reaffirmed offering strong earnings growth.

EPS forecasts moderated 2-6%.

The broker shaved its 12-month price target from $1.47 to $1.42.

This suggests a potential 40% upside ahead.

Healius Ltd (ASX: HLS)

The Healius share price is 43 cents, down 0.7% today and down 49% over 12 months. 

Since the healthcare sector began its long-awaited rebound on 3 June, Healius shares have soared 29%.

Morgans has a hold rating on this ASX 200 healthcare share following its FY26 report.

The broker said: 

FY26 results were mixed, with revenue and underlying EBITDA broadly in line, but underlying EBIT 5% below consensus and at the bottom of guidance, reflecting still-thin Pathology margins.

Encouragingly, Pathology EBIT margin improved materially in 2H, while labour costs fell 2.9% and group cost growth was contained.

Agilex was again a clear positive, with revenue and earnings growth ahead of expectations.

While FY27 EBIT guidance of A$39.7m is broadly in line with expectations, the T27 target for mid-to-high single-digit EBIT margins was extended by c18 months to Dec-28, leaving us cautious on the pace and sustainability of earnings leverage.

The broker increased its price target to 43 cents, implying the stock is fully valued.

BHP Group Ltd (ASX: BHP)

The BHP share price is $67.93, up 1.2% today and up 57% over 12 months. 

BHP shares reached a new record of $68.22 in earlier trading on Tuesday.

Morgans downgraded BHP shares to a sell call after its FY26 report on 18 August.

The broker explained: 

A solid FY26 result, with an upsized final dividend of US 99cps, against a share price that appears to already factor in more upside, we lower our rating to TRIM.

Metal prices were a key driver, but BHP also maintained a solid operating performance on controllable factors against a tough backdrop in FY26.

The broker reduced its 12-month price target from $59.80 to $55.30.

This suggests a potential 18% downside ahead.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ARB Corporation. The Motley Fool Australia has recommended ARB Corporation and BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Woman with her kitten on a laptop in her home office.
Broker Notes

Buy, hold, sell: Bendigo and Adelaide Bank, PLS, EOS shares

These three ASX shares posted their FY26 results this week. Find out what brokers tip next.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Bell Potter says this ASX biotech could nearly double in value

The US market is starting to open up for this company.

Read more »

Two work colleagues looking at a laptop and discussing something.
Broker Notes

Buy, hold, sell: DigiCo Infrastructure REIT, CBA, Telstra shares

Amid another day in the green for the ASX 200, experts reveal their new ratings.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

This ASX small-cap healthcare stock is tipped to double in value

This company has a good base to build on.

Read more »

Woman looking at her computer and pondering something.
Broker Notes

What is this broker's updated view on PLS shares after big results?

Where to next for this red hot stock?

Read more »

Senior man looking at his laptop and pondering something.
Broker Notes

Buy, hold, sell: Deterra Royalties, GQG Partners, and TPG Telecom shares

Morgans has updated its views on these popular stocks.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Broker Notes

With profits surging to $13.7 billion, are BHP shares a buy, hold or sell now?

A leading expert provides his forecast for BHP’s surging shares.

Read more »

Pensioner looking at his laptop.
Broker Notes

2 ASX shares that could rise up to 45% following earnings results 

These were earnings results winners.

Read more »